Global Uveitis Market 2014-2018 is a new market research publication announced by Reportstack. Uveitis is defined as the inflammation of the middle layer of the eye i.e. the uvea, also known as the uceal tract. The uvea consists of the iris, choroid and ciliary body. Infections, injury and autoimmune disorders may be related with the development of uveitis; however, the exact cause is often unknown. Various types of uveitis are: anterior uveitis, intermediate uveitis, posterior uveitis, and pan uveitis. The most common type of uveitis is an inflammation of the iris called iritis (anterior uveitis). Uveitis can be serious, leading to permanent vision loss.
The analysts forecast the Global Uveitis market will grow at a CAGR of 26.46 percent over the period 2013-2018.
The Global Uveitis market can be segmented into three divisions: the Americas, and the EMEA and APAC regions. To calculate the market size, the report considers the revenue generated from the sales of various therapies used in the treatment of uveitis.
The report Global Uveitis Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Uveitis market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• EMEA
• APAC
Key Vendors
• Abbvie Inc.
• Alcon Laboratories Inc.
• Allergan Inc.
• Bausch & Lomb Inc.Other Prominent Vendors
The analysts forecast the Global Uveitis market will grow at a CAGR of 26.46 percent over the period 2013-2018.
The Global Uveitis market can be segmented into three divisions: the Americas, and the EMEA and APAC regions. To calculate the market size, the report considers the revenue generated from the sales of various therapies used in the treatment of uveitis.
The report Global Uveitis Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Uveitis market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• EMEA
• APAC
Key Vendors
• Abbvie Inc.
• Alcon Laboratories Inc.
• Allergan Inc.
• Bausch & Lomb Inc.Other Prominent Vendors
• Artielle ImmunoTherapeutics Inc.
• Enzo Biochem Inc.
• Hanall Pharmaceutical Co. Ltd.
• Lux Biosciences Inc.
• OphthaliX Inc.
• Regeneron Pharmaceuticals Inc.
• TopiVert Ltd.
• pSivida Corp.
• XOMA Corp.
• Santen Pharmaceutical Co.
Key Market Driver
• Increasing Prevalence of Eye Disorders.
• For a full, detailed list, view our report.
Key Market Challenge
• Unknown Etiology of Uveitis.
• For a full, detailed list, view our report.
Key Market Trend
• Weak Competition in the Uveitis Market.
• For a full, detailed list, view our report.
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
• Enzo Biochem Inc.
• Hanall Pharmaceutical Co. Ltd.
• Lux Biosciences Inc.
• OphthaliX Inc.
• Regeneron Pharmaceuticals Inc.
• TopiVert Ltd.
• pSivida Corp.
• XOMA Corp.
• Santen Pharmaceutical Co.
Key Market Driver
• Increasing Prevalence of Eye Disorders.
• For a full, detailed list, view our report.
Key Market Challenge
• Unknown Etiology of Uveitis.
• For a full, detailed list, view our report.
Key Market Trend
• Weak Competition in the Uveitis Market.
• For a full, detailed list, view our report.
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
To view the table of contents and know more details please visit Global Uveitis Market 2014-2018.
No comments:
Post a Comment